| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 38 | 2024 | 1265 | 5.230 |
Why?
|
| Fetal Diseases | 24 | 2024 | 913 | 3.190 |
Why?
|
| Aneuploidy | 17 | 2023 | 552 | 2.700 |
Why?
|
| Hypoplastic Left Heart Syndrome | 18 | 2020 | 594 | 1.930 |
Why?
|
| Pregnancy | 138 | 2024 | 29868 | 1.830 |
Why?
|
| Ultrasonography, Prenatal | 40 | 2020 | 1754 | 1.800 |
Why?
|
| Aortic Valve Stenosis | 21 | 2022 | 2003 | 1.740 |
Why?
|
| Down Syndrome | 8 | 2020 | 901 | 1.680 |
Why?
|
| Chromosome Aberrations | 9 | 2020 | 1768 | 1.550 |
Why?
|
| Fetal Therapies | 12 | 2020 | 101 | 1.540 |
Why?
|
| Fetal Heart | 15 | 2024 | 281 | 1.440 |
Why?
|
| Congenital Abnormalities | 8 | 2020 | 709 | 1.390 |
Why?
|
| Genetic Diseases, Inborn | 6 | 2023 | 604 | 1.370 |
Why?
|
| Genetic Testing | 17 | 2023 | 3533 | 1.330 |
Why?
|
| Pregnancy Outcome | 26 | 2022 | 2921 | 1.260 |
Why?
|
| Chromosome Disorders | 9 | 2021 | 497 | 1.170 |
Why?
|
| Prenatal Care | 16 | 2023 | 1140 | 1.070 |
Why?
|
| Hypertension, Pregnancy-Induced | 3 | 2024 | 517 | 1.040 |
Why?
|
| Preimplantation Diagnosis | 3 | 2022 | 143 | 0.980 |
Why?
|
| Pre-Eclampsia | 8 | 2021 | 1230 | 0.950 |
Why?
|
| Obstetrics | 6 | 2023 | 666 | 0.950 |
Why?
|
| Reproductive Techniques, Assisted | 6 | 2015 | 496 | 0.900 |
Why?
|
| Gestational Age | 32 | 2021 | 3577 | 0.900 |
Why?
|
| Fetal Growth Retardation | 6 | 2015 | 580 | 0.850 |
Why?
|
| Pregnancy Complications | 18 | 2015 | 2948 | 0.840 |
Why?
|
| Mosaicism | 6 | 2017 | 474 | 0.810 |
Why?
|
| Stillbirth | 5 | 2020 | 368 | 0.800 |
Why?
|
| Sex Chromosome Aberrations | 3 | 2022 | 116 | 0.800 |
Why?
|
| Karyotyping | 11 | 2022 | 1171 | 0.770 |
Why?
|
| Amniocentesis | 2 | 2018 | 115 | 0.740 |
Why?
|
| Fertilization in Vitro | 7 | 2022 | 1292 | 0.710 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 2020 | 46 | 0.700 |
Why?
|
| Channelopathies | 1 | 2020 | 30 | 0.690 |
Why?
|
| Societies | 1 | 2020 | 107 | 0.690 |
Why?
|
| Postpartum Period | 3 | 2024 | 1178 | 0.680 |
Why?
|
| Nuchal Translucency Measurement | 4 | 2023 | 59 | 0.660 |
Why?
|
| Maternal-Fetal Exchange | 3 | 2020 | 461 | 0.660 |
Why?
|
| Catheterization | 10 | 2011 | 1428 | 0.650 |
Why?
|
| Hernia, Umbilical | 3 | 2009 | 102 | 0.620 |
Why?
|
| Pregnancy Trimester, First | 6 | 2016 | 908 | 0.610 |
Why?
|
| Alcohol Drinking | 12 | 2011 | 4025 | 0.610 |
Why?
|
| Vein of Galen Malformations | 3 | 2023 | 58 | 0.590 |
Why?
|
| Pregnancy Proteins | 3 | 2015 | 222 | 0.580 |
Why?
|
| Genomic Imprinting | 3 | 2015 | 329 | 0.570 |
Why?
|
| 22q11 Deletion Syndrome | 1 | 2017 | 18 | 0.570 |
Why?
|
| Female | 145 | 2024 | 392148 | 0.560 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2015 | 558 | 0.560 |
Why?
|
| Heart Defects, Congenital | 13 | 2024 | 4671 | 0.550 |
Why?
|
| Sex Chromosomes | 3 | 2023 | 101 | 0.550 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 2 | 2014 | 60 | 0.550 |
Why?
|
| Cordocentesis | 1 | 2016 | 10 | 0.540 |
Why?
|
| Gynecology | 5 | 2023 | 526 | 0.520 |
Why?
|
| Pulmonary Atresia | 2 | 2014 | 159 | 0.500 |
Why?
|
| Spouses | 3 | 2006 | 283 | 0.470 |
Why?
|
| Troponin | 1 | 2018 | 502 | 0.460 |
Why?
|
| Reproductive History | 1 | 2015 | 210 | 0.450 |
Why?
|
| alpha-Fetoproteins | 4 | 1998 | 222 | 0.450 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2014 | 81 | 0.450 |
Why?
|
| Fetus | 9 | 2023 | 1862 | 0.450 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 361 | 0.440 |
Why?
|
| Beckwith-Wiedemann Syndrome | 3 | 2009 | 45 | 0.430 |
Why?
|
| DNA | 9 | 2016 | 7196 | 0.430 |
Why?
|
| Placenta | 4 | 2017 | 1709 | 0.430 |
Why?
|
| Cardiology | 1 | 2024 | 1656 | 0.420 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2015 | 473 | 0.420 |
Why?
|
| Patient Transfer | 1 | 2019 | 793 | 0.410 |
Why?
|
| Infant, Newborn | 37 | 2023 | 26180 | 0.400 |
Why?
|
| Humans | 154 | 2024 | 760617 | 0.400 |
Why?
|
| Twins | 2 | 2011 | 340 | 0.400 |
Why?
|
| Diagnostic Errors | 3 | 2017 | 1265 | 0.390 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 786 | 0.390 |
Why?
|
| Pregnancy, High-Risk | 2 | 2018 | 121 | 0.380 |
Why?
|
| Chromosome Deletion | 2 | 2015 | 1386 | 0.380 |
Why?
|
| Genetic Counseling | 4 | 2021 | 627 | 0.370 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2014 | 462 | 0.370 |
Why?
|
| Pregnancy, Multiple | 2 | 2011 | 215 | 0.360 |
Why?
|
| Toluene | 3 | 1997 | 32 | 0.350 |
Why?
|
| Term Birth | 3 | 2016 | 138 | 0.350 |
Why?
|
| Ventricular Remodeling | 1 | 2018 | 1265 | 0.350 |
Why?
|
| Hydrops Fetalis | 3 | 2016 | 113 | 0.350 |
Why?
|
| DiGeorge Syndrome | 2 | 2023 | 185 | 0.340 |
Why?
|
| Pregnancy in Adolescence | 1 | 2011 | 163 | 0.340 |
Why?
|
| Temperance | 2 | 2006 | 87 | 0.340 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2018 | 1723 | 0.320 |
Why?
|
| Societies, Medical | 2 | 2020 | 3900 | 0.320 |
Why?
|
| Psychotherapy, Brief | 2 | 2006 | 118 | 0.310 |
Why?
|
| Echocardiography, Doppler | 4 | 2014 | 893 | 0.310 |
Why?
|
| Population Surveillance | 3 | 2015 | 2595 | 0.300 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2015 | 4007 | 0.300 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1349 | 0.290 |
Why?
|
| Alcoholism | 7 | 2011 | 1972 | 0.290 |
Why?
|
| Placenta Diseases | 4 | 2015 | 199 | 0.270 |
Why?
|
| Adult | 59 | 2024 | 220969 | 0.270 |
Why?
|
| Atrial Septum | 3 | 2017 | 60 | 0.270 |
Why?
|
| Ductus Arteriosus | 2 | 2020 | 42 | 0.270 |
Why?
|
| Neck | 1 | 2011 | 734 | 0.260 |
Why?
|
| Decidua | 1 | 2006 | 82 | 0.260 |
Why?
|
| Peptide Fragments | 1 | 2018 | 5110 | 0.250 |
Why?
|
| Cannabis | 1 | 2011 | 441 | 0.240 |
Why?
|
| Retrospective Studies | 32 | 2023 | 80566 | 0.230 |
Why?
|
| Trophoblasts | 1 | 2006 | 224 | 0.230 |
Why?
|
| Delivery, Obstetric | 4 | 2014 | 939 | 0.230 |
Why?
|
| Postnatal Care | 2 | 2024 | 260 | 0.230 |
Why?
|
| Overweight | 1 | 2015 | 2417 | 0.230 |
Why?
|
| Diabetes, Gestational | 3 | 2021 | 1250 | 0.220 |
Why?
|
| Puerperal Disorders | 2 | 2024 | 300 | 0.220 |
Why?
|
| Fathers | 1 | 2006 | 375 | 0.220 |
Why?
|
| Communication | 1 | 2017 | 3849 | 0.220 |
Why?
|
| Embolization, Therapeutic | 2 | 2023 | 1418 | 0.210 |
Why?
|
| Mass Screening | 6 | 2017 | 5424 | 0.210 |
Why?
|
| Heart Septal Defects, Atrial | 3 | 2014 | 451 | 0.200 |
Why?
|
| Internal Medicine | 2 | 2023 | 1051 | 0.200 |
Why?
|
| Amniotic Fluid | 2 | 2018 | 378 | 0.200 |
Why?
|
| Galactosemias | 1 | 2023 | 124 | 0.200 |
Why?
|
| Cerebral Veins | 1 | 2023 | 157 | 0.190 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2015 | 2509 | 0.190 |
Why?
|
| Diseases in Twins | 3 | 2015 | 446 | 0.190 |
Why?
|
| Epigenesis, Genetic | 3 | 2015 | 3794 | 0.190 |
Why?
|
| Body Mass Index | 3 | 2021 | 12943 | 0.190 |
Why?
|
| Goals | 1 | 2006 | 708 | 0.180 |
Why?
|
| Abortion, Induced | 2 | 2017 | 461 | 0.180 |
Why?
|
| Chorion | 4 | 2015 | 114 | 0.180 |
Why?
|
| Behavior Therapy | 1 | 2006 | 877 | 0.180 |
Why?
|
| Pandemics | 1 | 2020 | 8645 | 0.180 |
Why?
|
| Embryo Transfer | 2 | 2022 | 522 | 0.180 |
Why?
|
| Semen | 1 | 2023 | 347 | 0.180 |
Why?
|
| Infertility | 2 | 2023 | 654 | 0.170 |
Why?
|
| Blood Circulation | 1 | 2021 | 248 | 0.170 |
Why?
|
| Self Report | 1 | 2011 | 3723 | 0.170 |
Why?
|
| General Practitioners | 1 | 2021 | 90 | 0.170 |
Why?
|
| Ebstein Anomaly | 1 | 2020 | 105 | 0.170 |
Why?
|
| Trisomy | 2 | 2016 | 260 | 0.160 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2020 | 140 | 0.160 |
Why?
|
| Hernia, Diaphragmatic | 2 | 2012 | 244 | 0.160 |
Why?
|
| Substance-Related Disorders | 3 | 2011 | 4416 | 0.160 |
Why?
|
| Fetal Blood | 3 | 2023 | 1347 | 0.160 |
Why?
|
| Fetoscopy | 2 | 2009 | 133 | 0.160 |
Why?
|
| Decision Trees | 1 | 2020 | 504 | 0.150 |
Why?
|
| Neural Tube Defects | 2 | 1999 | 255 | 0.150 |
Why?
|
| Hemodynamics | 5 | 2022 | 4160 | 0.150 |
Why?
|
| Monosomy | 1 | 2017 | 52 | 0.150 |
Why?
|
| Maternal Age | 5 | 2010 | 809 | 0.150 |
Why?
|
| Tricuspid Valve | 1 | 2020 | 409 | 0.150 |
Why?
|
| Embryo, Mammalian | 2 | 2021 | 1670 | 0.140 |
Why?
|
| Vascular Malformations | 1 | 2023 | 468 | 0.140 |
Why?
|
| Oligospermia | 1 | 1997 | 59 | 0.140 |
Why?
|
| Genetics, Medical | 1 | 2000 | 334 | 0.140 |
Why?
|
| Cell-Free System | 2 | 2016 | 339 | 0.140 |
Why?
|
| Hypogonadism | 1 | 2023 | 798 | 0.140 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 352 | 0.140 |
Why?
|
| Teratogens | 1 | 1997 | 117 | 0.130 |
Why?
|
| Rh Isoimmunization | 1 | 2016 | 23 | 0.130 |
Why?
|
| Microinjections | 1 | 1997 | 321 | 0.130 |
Why?
|
| Physicians, Primary Care | 1 | 2023 | 617 | 0.130 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2021 | 512 | 0.130 |
Why?
|
| Choice Behavior | 2 | 2016 | 825 | 0.130 |
Why?
|
| Birth Weight | 3 | 2014 | 2101 | 0.130 |
Why?
|
| Abnormalities, Multiple | 4 | 2013 | 1422 | 0.130 |
Why?
|
| Patient Education as Topic | 2 | 2006 | 2315 | 0.130 |
Why?
|
| Face | 3 | 2001 | 1026 | 0.130 |
Why?
|
| Indomethacin | 2 | 2020 | 323 | 0.120 |
Why?
|
| Triploidy | 1 | 2014 | 3 | 0.120 |
Why?
|
| Fetal Resorption | 1 | 2014 | 15 | 0.120 |
Why?
|
| Sensitivity and Specificity | 7 | 2018 | 14648 | 0.120 |
Why?
|
| Abnormalities, Drug-Induced | 2 | 1997 | 339 | 0.120 |
Why?
|
| False Positive Reactions | 2 | 2015 | 957 | 0.120 |
Why?
|
| Coronary Circulation | 2 | 2018 | 1569 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2021 | 4789 | 0.120 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2014 | 31 | 0.120 |
Why?
|
| Ovary | 2 | 2023 | 959 | 0.120 |
Why?
|
| Vascular Diseases | 1 | 2023 | 1160 | 0.120 |
Why?
|
| Fertilization | 1 | 2015 | 198 | 0.120 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2014 | 40 | 0.110 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2013 | 730 | 0.110 |
Why?
|
| Adolescent | 12 | 2019 | 88234 | 0.110 |
Why?
|
| Nucleotides | 1 | 2016 | 453 | 0.110 |
Why?
|
| Nasal Bone | 1 | 2013 | 57 | 0.110 |
Why?
|
| Cesarean Section | 4 | 2014 | 1396 | 0.110 |
Why?
|
| Predictive Value of Tests | 9 | 2021 | 15251 | 0.110 |
Why?
|
| Phenotype | 5 | 2021 | 16571 | 0.110 |
Why?
|
| Obesity | 2 | 2015 | 12933 | 0.110 |
Why?
|
| Amnion | 2 | 2011 | 197 | 0.110 |
Why?
|
| Pleural Effusion | 1 | 1997 | 341 | 0.110 |
Why?
|
| Attitude of Health Personnel | 2 | 2013 | 3879 | 0.110 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 15498 | 0.110 |
Why?
|
| Young Adult | 9 | 2019 | 59179 | 0.110 |
Why?
|
| Ambulatory Care Facilities | 1 | 2019 | 934 | 0.110 |
Why?
|
| Qualitative Research | 1 | 2024 | 3016 | 0.110 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2012 | 1462 | 0.110 |
Why?
|
| Program Development | 1 | 2019 | 1293 | 0.110 |
Why?
|
| Risk Factors | 16 | 2021 | 74115 | 0.110 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 1380 | 0.110 |
Why?
|
| CHARGE Syndrome | 1 | 2012 | 33 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3777 | 0.100 |
Why?
|
| Spermatozoa | 1 | 1997 | 629 | 0.100 |
Why?
|
| Genomic Library | 1 | 2012 | 189 | 0.100 |
Why?
|
| Hydatidiform Mole | 1 | 2014 | 255 | 0.100 |
Why?
|
| Statistics, Nonparametric | 4 | 2013 | 2849 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2020 | 1600 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2023 | 2515 | 0.100 |
Why?
|
| Lactation | 1 | 2014 | 397 | 0.100 |
Why?
|
| Anencephaly | 1 | 1991 | 20 | 0.100 |
Why?
|
| Gene Rearrangement | 1 | 2016 | 1125 | 0.090 |
Why?
|
| Medical History Taking | 1 | 2015 | 773 | 0.090 |
Why?
|
| International Cooperation | 2 | 2015 | 1421 | 0.090 |
Why?
|
| Fetal Death | 4 | 2004 | 435 | 0.090 |
Why?
|
| Hepatitis B | 1 | 1996 | 702 | 0.090 |
Why?
|
| Treatment Outcome | 20 | 2022 | 64568 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2018 | 3634 | 0.090 |
Why?
|
| Male | 31 | 2023 | 360358 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2270 | 0.090 |
Why?
|
| Endocardial Fibroelastosis | 1 | 2010 | 56 | 0.090 |
Why?
|
| Case-Control Studies | 7 | 2015 | 22148 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 1 | 2015 | 869 | 0.090 |
Why?
|
| Chorionic Villi | 3 | 1995 | 53 | 0.090 |
Why?
|
| Fetofetal Transfusion | 3 | 2015 | 112 | 0.090 |
Why?
|
| CpG Islands | 1 | 2015 | 1192 | 0.090 |
Why?
|
| Cytogenetic Analysis | 1 | 2011 | 270 | 0.090 |
Why?
|
| Tocolytic Agents | 1 | 2009 | 24 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 2016 | 0.090 |
Why?
|
| Patient Readmission | 1 | 2024 | 3269 | 0.080 |
Why?
|
| Microcephaly | 1 | 1994 | 425 | 0.080 |
Why?
|
| Echocardiography, Doppler, Color | 2 | 2009 | 352 | 0.080 |
Why?
|
| Video-Assisted Surgery | 1 | 2009 | 51 | 0.080 |
Why?
|
| Ultrasonography, Doppler | 3 | 2020 | 462 | 0.080 |
Why?
|
| Gametogenesis | 1 | 2009 | 26 | 0.080 |
Why?
|
| Optical Phenomena | 1 | 2009 | 106 | 0.080 |
Why?
|
| Comorbidity | 2 | 2017 | 10505 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2018 | 6074 | 0.080 |
Why?
|
| Parents | 1 | 2022 | 3563 | 0.080 |
Why?
|
| Lipids | 2 | 2021 | 3332 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 2 | 2023 | 1496 | 0.080 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 470 | 0.080 |
Why?
|
| Massachusetts | 3 | 2013 | 8833 | 0.080 |
Why?
|
| Aortic Valve | 3 | 2009 | 1955 | 0.070 |
Why?
|
| Follow-Up Studies | 11 | 2014 | 39063 | 0.070 |
Why?
|
| Ventricular Function | 1 | 2009 | 406 | 0.070 |
Why?
|
| Risk | 2 | 2017 | 9604 | 0.070 |
Why?
|
| Obstetric Labor, Premature | 2 | 2010 | 272 | 0.070 |
Why?
|
| Heart Septum | 1 | 2008 | 299 | 0.070 |
Why?
|
| Chi-Square Distribution | 2 | 2006 | 3410 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2017 | 3621 | 0.070 |
Why?
|
| Infant, Premature | 3 | 2004 | 2107 | 0.070 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2007 | 41 | 0.070 |
Why?
|
| Recurrence | 1 | 2019 | 8426 | 0.070 |
Why?
|
| Social Facilitation | 1 | 2006 | 31 | 0.070 |
Why?
|
| Risk Assessment | 10 | 2020 | 23972 | 0.070 |
Why?
|
| Prospective Studies | 5 | 2022 | 54360 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2023 | 4668 | 0.070 |
Why?
|
| Boston | 3 | 2017 | 9313 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2021 | 6561 | 0.060 |
Why?
|
| Perinatal Mortality | 2 | 2020 | 101 | 0.060 |
Why?
|
| Reference Values | 3 | 2006 | 4919 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 1999 | 2518 | 0.060 |
Why?
|
| Live Birth | 2 | 2020 | 510 | 0.060 |
Why?
|
| Perinatology | 1 | 2005 | 63 | 0.060 |
Why?
|
| Hypertension | 2 | 2023 | 8529 | 0.060 |
Why?
|
| Twinning, Monozygotic | 2 | 2015 | 17 | 0.060 |
Why?
|
| Habits | 1 | 2006 | 147 | 0.060 |
Why?
|
| Blood Glucose | 2 | 2021 | 6390 | 0.060 |
Why?
|
| Thoracotomy | 1 | 2007 | 366 | 0.060 |
Why?
|
| Developmental Disabilities | 1 | 1994 | 1509 | 0.060 |
Why?
|
| Nurse-Patient Relations | 1 | 2005 | 99 | 0.060 |
Why?
|
| Cohort Studies | 7 | 2021 | 41457 | 0.060 |
Why?
|
| Heart Atria | 1 | 2011 | 1333 | 0.060 |
Why?
|
| Infarction | 1 | 2006 | 248 | 0.060 |
Why?
|
| Drug Tolerance | 1 | 2006 | 367 | 0.060 |
Why?
|
| Probability | 3 | 2023 | 2475 | 0.060 |
Why?
|
| ROC Curve | 3 | 2010 | 3575 | 0.060 |
Why?
|
| Family | 1 | 2015 | 3193 | 0.060 |
Why?
|
| Echocardiography | 2 | 2020 | 4987 | 0.060 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2006 | 284 | 0.060 |
Why?
|
| Lymphatic System | 1 | 2005 | 253 | 0.050 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2004 | 137 | 0.050 |
Why?
|
| Maternal Behavior | 1 | 2006 | 307 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2012 | 8618 | 0.050 |
Why?
|
| Infant, Premature, Diseases | 1 | 2009 | 710 | 0.050 |
Why?
|
| HELLP Syndrome | 2 | 2006 | 40 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2011 | 2118 | 0.050 |
Why?
|
| Time Factors | 5 | 2020 | 39913 | 0.050 |
Why?
|
| Stents | 1 | 2014 | 3178 | 0.050 |
Why?
|
| Teratoma | 1 | 2005 | 404 | 0.050 |
Why?
|
| Ethics Committees, Research | 1 | 2023 | 196 | 0.050 |
Why?
|
| Middle Cerebral Artery | 2 | 2015 | 274 | 0.050 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2011 | 1400 | 0.050 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2001 | 112 | 0.050 |
Why?
|
| Logistic Models | 3 | 2021 | 13245 | 0.050 |
Why?
|
| Constriction | 1 | 2020 | 168 | 0.050 |
Why?
|
| Ultrasonography | 4 | 2023 | 5964 | 0.040 |
Why?
|
| Twins, Conjoined | 1 | 2000 | 41 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2015 | 4391 | 0.040 |
Why?
|
| Infant | 6 | 2023 | 36152 | 0.040 |
Why?
|
| Gene Expression | 1 | 1993 | 7568 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2001 | 313 | 0.040 |
Why?
|
| Airway Obstruction | 1 | 2005 | 661 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2005 | 1037 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 2726 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2015 | 8472 | 0.040 |
Why?
|
| Fatty Liver | 1 | 2006 | 787 | 0.040 |
Why?
|
| Vinblastine | 1 | 2001 | 488 | 0.040 |
Why?
|
| Middle Aged | 8 | 2019 | 220584 | 0.040 |
Why?
|
| Health Education | 1 | 2006 | 1049 | 0.040 |
Why?
|
| Dystocia | 1 | 1999 | 34 | 0.040 |
Why?
|
| Mutation | 4 | 2012 | 30016 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2001 | 535 | 0.040 |
Why?
|
| Ibuprofen | 1 | 2020 | 229 | 0.040 |
Why?
|
| Registries | 1 | 2015 | 8207 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2022 | 748 | 0.040 |
Why?
|
| Models, Animal | 1 | 2005 | 2109 | 0.040 |
Why?
|
| Translocation, Genetic | 2 | 2016 | 1392 | 0.040 |
Why?
|
| Cervical Vertebrae | 1 | 2005 | 976 | 0.040 |
Why?
|
| Heart Failure | 1 | 2023 | 11669 | 0.040 |
Why?
|
| Chorionic Villi Sampling | 2 | 2001 | 35 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2019 | 189 | 0.040 |
Why?
|
| Spinal Neoplasms | 1 | 2005 | 703 | 0.040 |
Why?
|
| Maternal Exposure | 1 | 2006 | 1067 | 0.040 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2001 | 258 | 0.040 |
Why?
|
| Abdominal Muscles | 1 | 1999 | 169 | 0.040 |
Why?
|
| Lung | 1 | 2017 | 9998 | 0.040 |
Why?
|
| Self Disclosure | 1 | 1999 | 249 | 0.040 |
Why?
|
| Fertility | 1 | 2023 | 769 | 0.040 |
Why?
|
| Genome, Human | 3 | 2016 | 4421 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 14591 | 0.040 |
Why?
|
| Reproducibility of Results | 6 | 2013 | 20074 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2009 | 3796 | 0.040 |
Why?
|
| Counseling | 1 | 2005 | 1538 | 0.040 |
Why?
|
| Income | 1 | 2006 | 1870 | 0.040 |
Why?
|
| Estriol | 1 | 1996 | 53 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2021 | 633 | 0.030 |
Why?
|
| Acidosis, Renal Tubular | 1 | 1997 | 50 | 0.030 |
Why?
|
| Central Nervous System Depressants | 1 | 1998 | 164 | 0.030 |
Why?
|
| Obstetric Labor Complications | 1 | 1999 | 236 | 0.030 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 376 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2024 | 2697 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 2016 | 4611 | 0.030 |
Why?
|
| Premature Birth | 1 | 2009 | 1782 | 0.030 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 26049 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2005 | 6224 | 0.030 |
Why?
|
| Growth Disorders | 1 | 2001 | 634 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2013 | 582 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2017 | 15612 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2016 | 145 | 0.030 |
Why?
|
| Social Support | 1 | 2006 | 2174 | 0.030 |
Why?
|
| Suction | 1 | 1997 | 266 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2016 | 192 | 0.030 |
Why?
|
| DNA Probes | 1 | 1996 | 541 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2016 | 247 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2007 | 2630 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2023 | 7995 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 1996 | 302 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1996 | 293 | 0.030 |
Why?
|
| Incidence | 3 | 2013 | 21337 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2020 | 42188 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 15908 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 4739 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2016 | 573 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2005 | 2688 | 0.030 |
Why?
|
| Fasting | 1 | 2021 | 1603 | 0.030 |
Why?
|
| Parity | 2 | 2010 | 924 | 0.030 |
Why?
|
| Chorionic Gonadotropin | 1 | 1996 | 457 | 0.030 |
Why?
|
| Ploidies | 1 | 1995 | 285 | 0.030 |
Why?
|
| Health Behavior | 1 | 2006 | 2643 | 0.030 |
Why?
|
| Polycythemia | 1 | 2015 | 124 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 1997 | 1156 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 1999 | 905 | 0.030 |
Why?
|
| Educational Status | 1 | 2021 | 2509 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2021 | 2423 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 1996 | 1178 | 0.030 |
Why?
|
| Barotrauma | 1 | 2012 | 39 | 0.030 |
Why?
|
| Nutritional Requirements | 1 | 2014 | 274 | 0.030 |
Why?
|
| Cytoplasm | 1 | 1997 | 1503 | 0.030 |
Why?
|
| Thrombosis | 1 | 2006 | 2943 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1996 | 701 | 0.020 |
Why?
|
| Fragile X Syndrome | 1 | 1993 | 116 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 12043 | 0.020 |
Why?
|
| Primary Prevention | 1 | 2019 | 1185 | 0.020 |
Why?
|
| Ethanol | 1 | 1998 | 1320 | 0.020 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2014 | 269 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2013 | 560 | 0.020 |
Why?
|
| Animals | 6 | 2023 | 168201 | 0.020 |
Why?
|
| Lung Volume Measurements | 1 | 2012 | 375 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5239 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 12142 | 0.020 |
Why?
|
| Women's Health | 1 | 2000 | 2065 | 0.020 |
Why?
|
| Child | 5 | 2020 | 80079 | 0.020 |
Why?
|
| Edema | 1 | 1995 | 765 | 0.020 |
Why?
|
| Gene Deletion | 2 | 2001 | 2661 | 0.020 |
Why?
|
| Primates | 1 | 1993 | 521 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 1993 | 623 | 0.020 |
Why?
|
| Disease Progression | 2 | 2020 | 13495 | 0.020 |
Why?
|
| Incidental Findings | 1 | 2015 | 697 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2015 | 823 | 0.020 |
Why?
|
| Mesoderm | 1 | 1993 | 674 | 0.020 |
Why?
|
| Umbilical Arteries | 1 | 2010 | 79 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2020 | 2978 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2012 | 311 | 0.020 |
Why?
|
| Parenteral Nutrition | 1 | 2014 | 659 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1997 | 4010 | 0.020 |
Why?
|
| Diastole | 1 | 2011 | 781 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 29600 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2014 | 589 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 36402 | 0.020 |
Why?
|
| Expert Testimony | 1 | 2011 | 364 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2009 | 452 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2013 | 9643 | 0.020 |
Why?
|
| Life Style | 1 | 2019 | 3904 | 0.020 |
Why?
|
| Anthropometry | 1 | 2012 | 1338 | 0.020 |
Why?
|
| Maternal Mortality | 1 | 2010 | 301 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 2114 | 0.020 |
Why?
|
| Public Opinion | 1 | 2011 | 484 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2000 | 6233 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2007 | 151 | 0.020 |
Why?
|
| Skull | 1 | 1991 | 818 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 1997 | 1813 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1997 | 4242 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2020 | 3232 | 0.020 |
Why?
|
| Neoplasms | 1 | 2015 | 22131 | 0.020 |
Why?
|
| Energy Intake | 1 | 2014 | 2132 | 0.020 |
Why?
|
| Patient Selection | 1 | 2018 | 4237 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2009 | 1096 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 1999 | 3239 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 1996 | 2768 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 6861 | 0.020 |
Why?
|
| Consensus | 1 | 2015 | 3117 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2009 | 1813 | 0.010 |
Why?
|
| Severity of Illness Index | 3 | 2007 | 15828 | 0.010 |
Why?
|
| Education | 1 | 2007 | 534 | 0.010 |
Why?
|
| Brain | 1 | 1991 | 27101 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1997 | 5491 | 0.010 |
Why?
|
| Head | 1 | 2010 | 922 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6474 | 0.010 |
Why?
|
| United States | 3 | 2023 | 72272 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 6340 | 0.010 |
Why?
|
| Linear Models | 1 | 2013 | 5866 | 0.010 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2001 | 5319 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12661 | 0.010 |
Why?
|
| Demography | 1 | 2006 | 1643 | 0.010 |
Why?
|
| Canada | 1 | 2007 | 2118 | 0.010 |
Why?
|
| Chromosome Painting | 1 | 2001 | 26 | 0.010 |
Why?
|
| Glypicans | 1 | 2001 | 33 | 0.010 |
Why?
|
| Lymphangioma, Cystic | 1 | 2001 | 34 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 2001 | 260 | 0.010 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2005 | 576 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2007 | 909 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2001 | 777 | 0.010 |
Why?
|
| Genomics | 1 | 2016 | 5822 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2006 | 2925 | 0.010 |
Why?
|
| Prevalence | 1 | 1997 | 15689 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2001 | 11736 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 11874 | 0.010 |
Why?
|
| Genotype | 1 | 1993 | 12978 | 0.010 |
Why?
|
| Sampling Studies | 1 | 1999 | 615 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2006 | 1808 | 0.010 |
Why?
|
| X Chromosome | 1 | 2001 | 816 | 0.010 |
Why?
|
| Apoptosis | 1 | 2013 | 9476 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1997 | 18221 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1999 | 17878 | 0.010 |
Why?
|
| Personality Inventory | 1 | 2000 | 1018 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 7389 | 0.010 |
Why?
|
| Family Health | 1 | 2001 | 1253 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 13382 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2001 | 2340 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 81368 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 12966 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2008 | 6346 | 0.010 |
Why?
|
| Syndrome | 1 | 2001 | 3268 | 0.010 |
Why?
|
| Mental Health Services | 1 | 2006 | 1717 | 0.010 |
Why?
|
| Cisplatin | 1 | 2001 | 1650 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 9461 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12719 | 0.010 |
Why?
|
| Heart | 1 | 2007 | 4403 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 10073 | 0.010 |
Why?
|
| Pedigree | 1 | 2001 | 4539 | 0.010 |
Why?
|
| Yolk Sac | 1 | 1993 | 79 | 0.010 |
Why?
|
| Observer Variation | 1 | 1999 | 2606 | 0.010 |
Why?
|
| Dyspnea | 1 | 2001 | 1347 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2000 | 20988 | 0.010 |
Why?
|
| Oxygen | 1 | 2001 | 4226 | 0.010 |
Why?
|
| Pneumonia | 1 | 2001 | 2143 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 1999 | 7798 | 0.000 |
Why?
|
| Smoking | 1 | 2001 | 9050 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 8998 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1993 | 11514 | 0.000 |
Why?
|